表紙
市場調查報告書

腹部主動脈覆膜支架:醫療設備的開發平台分析

Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019

出版商 GlobalData 商品編碼 374725
出版日期 內容資訊 英文 133 Pages
訂單完成後即時交付
價格
Back to Top
腹部主動脈覆膜支架:醫療設備的開發平台分析 Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019
出版日期: 2019年12月18日內容資訊: 英文 133 Pages
簡介

本報告提供全球各國的企業·醫療機關等開發中的腹部主動脈覆膜支架之開發中產品資訊相關分析,提供您臨床實驗/產品開發的整體進展,及各階段·各地區·各領域詳細趨勢,各企業·各產品的詳細資訊 (臨床實驗的進展階段,開始/結束時期,認證預測等),近來的產品開發·資本交易的動向等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 腹部主動脈覆膜支架概要

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 腹部主動脈覆膜支架:開發中的開發中產品 (各企業)

  • 腹部主動脈覆膜支架的開發企業:開發中產品 (各開發階段)
  • 腹部主動脈覆膜支架:各開發階段的開發中產品一覽

第5章 腹部主動脈覆膜支架的開發企業·產品概要

  • BiFlow Medical Ltd
    • 開發中產品及進行中的臨床實驗概要
  • Bolton Medical, Inc.
  • Cardiatis SA
  • Cardiovate
  • Cook Medical Incorporated
  • Cordis Corporation
  • Cytograft Tissue Engineering, Inc.
  • Endologix, Inc.
  • Endoluminal Sciences Pty Ltd.
  • EndoSpan Ltd
  • Lombard Medical Technologies Inc.
  • Lombard Medical Technologies Limited
  • Medtronic plc
  • MicroPort Scientific Corporation
  • St. Jude Medical, Inc.
  • TriVascular, Inc.
  • University of Limerick
  • Venus MedTech
  • W. L. Gore & Associates, Inc.

第6章 腹部主動脈覆膜支架:近來的市場趨勢 (全72件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0880EPD

GlobalData's Medical Devices sector report, "Abdominal Aortic Stent Grafts - Medical Devices Pipeline Assessment, 2019" provides an overview of Abdominal Aortic Stent Grafts currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Abdominal Aortic Stent Grafts pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Abdominal Aortic Stent Grafts under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 5
  • 1.2 List of Figures 8

2 Introduction 9

  • 2.1 Abdominal Aortic Stent Grafts Overview 9

3 Products under Development 10

  • 3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 10
  • 3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Territory 11
  • 3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path 12
  • 3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date 13
  • 3.5 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials 14

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies 15

  • 4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development 15
  • 4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development 16

5 Abdominal Aortic Stent Grafts Companies and Product Overview 18

  • 5.1 Affluent Medical SA Company Overview 18
    • 5.1.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 18
  • 5.2 Altura Medical Inc Company Overview 21
    • 5.2.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
  • 5.3 Angiolutions UG Company Overview 24
    • 5.3.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.4 Aortica Corp Company Overview 25
    • 5.4.1 Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.5 BiFlow Medical Ltd Company Overview 26
    • 5.5.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
  • 5.6 Cook Medical Inc Company Overview 27
    • 5.6.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 Cordis Corp Company Overview 31
    • 5.7.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.8 Cytograft Tissue Engineering Inc (Inactive) Company Overview 35
    • 5.8.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.9 Endologix Inc Company Overview 36
    • 5.9.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 36
  • 5.10 Endoluminal Sciences Pty Ltd. Company Overview 51
    • 5.10.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.11 Hadassah Medical Center Company Overview 52
    • 5.11.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.12 JOTEC GmbH Company Overview 53
    • 5.12.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.13 Kawasumi Laboratories Inc Company Overview 56
    • 5.13.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.14 Lombard Medical Technologies Inc. Company Overview 57
    • 5.14.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.15 Lombard Medical Technologies Ltd Company Overview 58
    • 5.15.1 Lombard Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.16 Medtronic plc Company Overview 64
    • 5.16.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 64
  • 5.17 St. Jude Medical LLC Company Overview 67
    • 5.17.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.18 Terumo Aortic Company Overview 68
    • 5.18.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview 68
  • 5.19 University of Colorado Denver Company Overview 76
    • 5.19.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.20 University of Limerick Company Overview 77
    • 5.20.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.21 Venus MedTech Company Overview 78
    • 5.21.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.22 W. L. Gore & Associates Inc Company Overview 79
    • 5.22.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview 79

6 Abdominal Aortic Stent Grafts- Recent Developments 84

  • 6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 84
  • 6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 86
  • 6.3 Nov 12, 2019: W. L. Gore & Associates to reveal new gender insights from real-world aortic data At 2019 VEITHsymposium 87
  • 6.4 Nov 12, 2019: Cook Medical's leadership updates in Asia-pacific reinforce focus on growth and physician relationships 88
  • 6.5 Nov 06, 2019: Endologix reports third quarter 2019 financial results 88

7 Appendix 130

  • 7.1 Methodology 130
  • 7.2 About GlobalData 133
  • 7.3 Contact Us 133
  • 7.4 Disclaimer 133

List of Tables

  • Table 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Table 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory
  • Table 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Table 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Table 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
  • Table 6: Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
  • Table 7: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Table 8: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Kardiozis - Product Status
  • Table 10: Kardiozis - Product Description
  • Table 11: Affluent Medical SA - Ongoing Clinical Trials Overview
  • Table 12: Kardiozis - Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination with Coil Embolisation of the Aneurysmal Sac
  • Table 13: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: Altura Endograft System - Product Status
  • Table 15: Altura Endograft System - Product Description
  • Table 16: Altura Medical Inc - Ongoing Clinical Trials Overview
  • Table 17: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion: ELEVATE International
  • Table 18: Altura Endograft System - Multi-center Observational Post-market Real World Registry
  • Table 19: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms
  • Table 20: Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview
  • Table 21: Vascular Graft (A3-Shield) - Product Status
  • Table 22: Vascular Graft (A3-Shield) - Product Description
  • Table 23: Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 24: BoulEVARd Stent - Product Status
  • Table 25: BoulEVARd Stent - Product Description
  • Table 26: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status
  • Table 28: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description
  • Table 29: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 30: Zenith p-Branch - Product Status
  • Table 31: Zenith p-Branch - Product Description
  • Table 32: Cook Medical Inc - Ongoing Clinical Trials Overview
  • Table 33: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts
  • Table 34: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion
  • Table 35: Zenith p-Branch - Zenith p-Branch Multi-center Study
  • Table 36: Zenith p-Branch - Zenith p-Branch Pivotal Study
  • Table 37: Zenith p-Branch - Zenith p-Branch: Single-center Study
  • Table 38: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Table 39: INCRAFT AAA Stent Graft - Product Status
  • Table 40: INCRAFT AAA Stent Graft - Product Description
  • Table 41: Cordis Corp - Ongoing Clinical Trials Overview
  • Table 42: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms: INSPIRATION
  • Table 43: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms
  • Table 44: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post-market Study of the INCRAFT AAA Stent Graft in Subjects with Abdominal Aortic Aneurysms
  • Table 45: INCRAFT AAA Stent Graft - Korean Registry of Percutaneous EVAR with INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
  • Table 46: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: LifeJacket AAA Stent Graft - Product Status
  • Table 48: LifeJacket AAA Stent Graft - Product Description
  • Table 49: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: AFX2 Bifurcated Endograft System - Product Status
  • Table 51: AFX2 Bifurcated Endograft System - Product Description
  • Table 52: AFX3 - Product Status
  • Table 53: AFX3 - Product Description
  • Table 54: AFX4 - Product Status
  • Table 55: AFX4 - Product Description
  • Table 56: Nellix 3.5 - Product Status
  • Table 57: Nellix 3.5 - Product Description
  • Table 58: Nellix CHEVAS - Product Status
  • Table 59: Nellix CHEVAS - Product Description
  • Table 60: Nellix EVAS System - Product Status
  • Table 61: Nellix EVAS System - Product Description

List of Figures

  • Figure 1: Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
  • Figure 2: Abdominal Aortic Stent Grafts - Pipeline Products by Territory
  • Figure 3: Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
  • Figure 4: Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
  • Figure 5: Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
Back to Top